181 related articles for article (PubMed ID: 26739486)
21. The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cells.
Nagumo H; Agematsu K; Kobayashi N; Shinozaki K; Hokibara S; Nagase H; Takamoto M; Yasui K; Sugane K; Komiyama A
Blood; 2002 Jan; 99(2):567-75. PubMed ID: 11781240
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Caushi JX; Zhang J; Ji Z; Vaghasia A; Zhang B; Hsiue EH; Mog BJ; Hou W; Justesen S; Blosser R; Tam A; Anagnostou V; Cottrell TR; Guo H; Chan HY; Singh D; Thapa S; Dykema AG; Burman P; Choudhury B; Aparicio L; Cheung LS; Lanis M; Belcaid Z; El Asmar M; Illei PB; Wang R; Meyers J; Schuebel K; Gupta A; Skaist A; Wheelan S; Naidoo J; Marrone KA; Brock M; Ha J; Bush EL; Park BJ; Bott M; Jones DR; Reuss JE; Velculescu VE; Chaft JE; Kinzler KW; Zhou S; Vogelstein B; Taube JM; Hellmann MD; Brahmer JR; Merghoub T; Forde PM; Yegnasubramanian S; Ji H; Pardoll DM; Smith KN
Nature; 2021 Aug; 596(7870):126-132. PubMed ID: 34290408
[TBL] [Abstract][Full Text] [Related]
23. Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer.
Yasuda M; Mizukami M; Hanagiri T; Shigematsu Y; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(5A):3607-11. PubMed ID: 17094490
[TBL] [Abstract][Full Text] [Related]
24. Peripheral blood and tumor infiltrating lymphocytes in non-small cell lung cancer: analysis at the population and clonal level.
Viale M; Ferrini S; Serrano S; Serrano D; Ardizzoni A; Nicolin A
Tumori; 1990 Oct; 76(5):488-94. PubMed ID: 2175060
[TBL] [Abstract][Full Text] [Related]
25. The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response.
Willis SN; Mallozzi SS; Rodig SJ; Cronk KM; McArdel SL; Caron T; Pinkus GS; Lovato L; Shampain KL; Anderson DE; Anderson RC; Bruce JN; O'Connor KC
J Immunol; 2009 Mar; 182(5):3310-7. PubMed ID: 19234230
[TBL] [Abstract][Full Text] [Related]
26. An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.
Quan H; Fang L; Pan H; Deng Z; Gao S; Liu O; Wang Y; Hu Y; Fang X; Yao Z; Guo F; Lu R; Xia K; Tang Z
Int J Cancer; 2016 Jun; 138(12):2952-62. PubMed ID: 26815146
[TBL] [Abstract][Full Text] [Related]
27. Killing of laminin receptor-positive human lung cancers by tumor infiltrating lymphocytes bearing gammadelta(+) t-cell receptors.
Ferrarini M; Heltai S; Pupa SM; Mernard S; Zocchi R
J Natl Cancer Inst; 1996 Apr; 88(7):436-41. PubMed ID: 8618235
[TBL] [Abstract][Full Text] [Related]
28. Local Clonal Diversification and Dissemination of B Lymphocytes in the Human Bronchial Mucosa.
Ohm-Laursen L; Meng H; Chen J; Zhou JQ; Corrigan CJ; Gould HJ; Kleinstein SH
Front Immunol; 2018; 9():1976. PubMed ID: 30245687
[TBL] [Abstract][Full Text] [Related]
29. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F
J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384
[TBL] [Abstract][Full Text] [Related]
30. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages.
Vieira T; Antoine M; Hamard C; Fallet V; Duruisseaux M; Rabbe N; Rodenas A; Cadranel J; Wislez M
Lung Cancer; 2016 Aug; 98():51-58. PubMed ID: 27393506
[TBL] [Abstract][Full Text] [Related]
31. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
32. TCR Repertoire Analysis Reveals Mobilization of Novel CD8
Aoki H; Ueha S; Shichino S; Ogiwara H; Hashimoto SI; Kakimi K; Ito S; Matsushima K
Front Immunol; 2018; 9():3185. PubMed ID: 30733724
[TBL] [Abstract][Full Text] [Related]
33. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients.
Djenidi F; Adam J; Goubar A; Durgeau A; Meurice G; de Montpréville V; Validire P; Besse B; Mami-Chouaib F
J Immunol; 2015 Apr; 194(7):3475-86. PubMed ID: 25725111
[TBL] [Abstract][Full Text] [Related]
34. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
[TBL] [Abstract][Full Text] [Related]
35. A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma.
Nishizaka S; Gomi S; Harada K; Oizumi K; Itoh K; Shichijo S
Cancer Res; 2000 Sep; 60(17):4830-7. PubMed ID: 10987294
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel tumor antigens with patient-derived immune-selected antibodies.
Rodriguez-Pinto D; Sparkowski J; Keough MP; Phoenix KN; Vumbaca F; Han DK; Gundelfinger ED; Beesley P; Claffey KP
Cancer Immunol Immunother; 2009 Feb; 58(2):221-34. PubMed ID: 18568347
[TBL] [Abstract][Full Text] [Related]
37. Peptides from the variable region of specific antibodies are shared among lung cancer patients.
de Costa D; Broodman I; Calame W; Stingl C; Dekker LJ; Vernhout RM; de Koning HJ; Hoogsteden HC; Sillevis Smitt PA; van Klaveren RJ; Luider TM; Vanduijn MM
PLoS One; 2014; 9(5):e96029. PubMed ID: 24787687
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.
Handa Y; Tsutani Y; Shiroma N; Kai Y; Mimae T; Miyata Y; Takeshima Y; Arihiro K; Okada M
Clin Lung Cancer; 2020 Jul; 21(4):e302-e314. PubMed ID: 32102750
[TBL] [Abstract][Full Text] [Related]
39. Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens.
DeFalco J; Harbell M; Manning-Bog A; Baia G; Scholz A; Millare B; Sumi M; Zhang D; Chu F; Dowd C; Zuno-Mitchell P; Kim D; Leung Y; Jiang S; Tang X; Williamson KS; Chen X; Carroll SM; Espiritu Santo G; Haaser N; Nguyen N; Giladi E; Minor D; Tan YC; Sokolove JB; Steinman L; Serafini TA; Cavet G; Greenberg NM; Glanville J; Volkmuth W; Emerling DE; Robinson WH
Clin Immunol; 2018 Feb; 187():37-45. PubMed ID: 29031828
[TBL] [Abstract][Full Text] [Related]
40. TCR repertoires of intratumoral T-cell subsets.
Linnemann C; Mezzadra R; Schumacher TN
Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
